Valion Bio, Inc. - 8-K Filing

Valion Bio highlights Velocity Bioworks CDMO capabilities amid Section 232 tariffs impacting biotech manufacturing (Items: 8.01 Other Matters, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $TIVC

Read the full article at SEC EDGAR

More Regulatory news